Insights

Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discu... read more

The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers. read more

With the pharmacy resident recruiting season right around the corner, Tony Huke provides five tips to help you choose the best candidates for your program. read more

What started as a concept on the back of a napkin has grown into a full-fledged dedicated resource program geared towards helping providers enhance their pharmaceutical enterprise. read more

What started as a concept on the back of a napkin has grown into a full-fledged dedicated resource program geared towards helping providers enhance their pharmaceutical enterprise. read more

Drug Shortage Stewardship, a new concept that proposes a demand-side national approach, could be another tools to use when faced with the ever-present challenge of drug shortages. read more

Biosimilars are a hot topic in pharmacy right now, but will they really have an impact on the pharmaceutical industry? Senior Principal of Pharmacy Solutions Steven Lucio answers this question and mo... read more

There have been many pharmaceutical changes in the cardiology service line in the past year – here’s what they are and why. read more

Some of the activities we enjoy so much during the summer can also put us at an increased risk of contracting tetanus. That’s why it’s important to be sure your tetanus vaccine is up to date. read more

Monkeypox has been declared a public health emergency. Here are some of the facts you should know. read more